MedTrace Logo

Understanding the Burden of ACC Through the Eyes of Patients

NCT04706845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2023-09-29

No results posted yet for this study

Summary

This is a comprehensive, cross-sectional study conducted with approximately 40-60 individuals affected by ACC who may know the results of molecular profiling of their tumor.

Primary Objectives:

* To identify the specific burdens faced by patients with ACC
* To compare/contrast the burdens faced by patients with ACC at different disease stages (no evident disease, metastatic disease/watchful waiting, progressive disease)

Conditions

  • Adenoid Cystic Carcinoma

Sponsors & Collaborators

  • Adenoid Cystic Carcinoma Research Foundation

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    collaborator OTHER

  • Hadassah Medical Organization

    collaborator OTHER

  • Engage Health Inc.

    collaborator INDUSTRY

  • Ayala Pharmaceuticals, Inc,

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-11
Primary Completion
2023-08-16
Completion
2023-08-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04706845 on ClinicalTrials.gov